Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjects.

This study was designed to investigate the response of Type III hyperlipoproteinemic subjects to bezafibrate therapy. The metabolism of apolipoprotein B was examined in four lipoprotein subclasses of Sf 60-400 (large very low density lipoprotein (VLDL)), Sf 20-60 (small VLDL), Sf 12-20 (intermediate...

Full description

Bibliographic Details
Main Authors: C J Packard, R J Clegg, M H Dominiczak, A R Lorimer, J Shepherd
Format: Article
Language:English
Published: Elsevier 1990-04-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520387757